Document is current
Any future updates will be listed below
-
Authors
Salardini, Elaheh
O’Dell, Ryan S.
Tchorz, Em
Nabulsi, Nabeel B.
Huang, Yiyun
Carson, Richard E.
van Dyck, Christopher H.
Mecca, Adam P.
-
Funding
Funding for this research was provided by:
National Institute on Aging (R01AG052560, R01AG052560, K23AG057794)
- License Information
-
More Information
Article History
Received: 17 December 2024
Accepted: 10 April 2025
First Online: 6 May 2025
Declarations
:
: The study protocol was approved by the Yale University Human Investigation Committee and Radiation Safety Committee. All participants provided written informed consent prior to participating in the study.
: Not applicable.
: A.P.M., R.E.C., and C.H.vD. report grants from the National Institutes of Health for the conduct of the study. A.P.M. reports grants for clinical trials from Eli Lilly and Janssen Pharmaceuticals outside the submitted work. Y.H. reports research grants from UCB and Eli Lilly outside the submitted work. Y.H., N.B.N., and R.E.C. have a patent for a newer version of the tracer. R.E.C. is a consultant for Rodin Therapeutics and has received research funding from UCB. R.E.C. reports having received grants from AstraZeneca, Astellas, Eli Lilly, Pfizer, Taisho, and UCB outside the submitted work. C.H.vD. reports consulting fees from Kyowa Kirin, Roche, Merck, Eli Lilly, and Janssen and grants for clinical trials from Biogen, Novartis, Eli Lilly, Merck, Eisai, Janssen, Roche, Genentech, Toyama, and Biohaven outside the submitted work. R.S.O. reports grants for clinical trials from Cognition Therapeutics and Bristol-Myers Squibb outside of the submitted work.
